Cargando…
Treatment and outcome of patients with Graves’ disease and metastatic differentiated thyroid cancer
BACKGROUND: The aim of the study was to report on the experience in a single tertiary cancer center about the treatment and outcome of patients with Graves’ disease (GD) and metastatic thyroid cancer as compared with patients without GD in our country. PATIENTS AND METHODS: Altogether, 28 patients (...
Autores principales: | Besic, Nikola, Vidergar-Kralj, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476900/ https://www.ncbi.nlm.nih.gov/pubmed/37665744 http://dx.doi.org/10.2478/raon-2023-0034 |
Ejemplares similares
-
Graves disease and metastatic hormonal-active Hürthle cell thyroid cancer: A case report
por: Besic, Nikola, et al.
Publicado: (2021) -
Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Patients with Metastatic Differentiated Thyroid Carcinoma
por: Zagar, Ivana, et al.
Publicado: (2012) -
Treatment and outcome of 32 patients with distant metastases of Hürthle cell thyroid carcinoma: a single-institution experience
por: Besic, Nikola, et al.
Publicado: (2016) -
Characteristics, staging and outcomes of differentiated thyroid cancer in patients with and without Graves’ disease
por: Gopinath, Chaitra, et al.
Publicado: (2023) -
Clinicopathologic Features and Treatment Outcomes in Differentiated Thyroid Carcinoma Patients with Concurrent Graves' Disease
por: Lee, Jandee, et al.
Publicado: (2008)